Truist Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,333
| Closed | -$378K | – | 2642 |
|
|
2024
Q1 | $378K | Sell |
4,333
-2,348
| -35% | -$205K | ﹤0.01% | 2152 |
|
|
2023
Q4 | $644K | Buy |
6,681
+1,067
| +19% | +$103K | ﹤0.01% | 1826 |
|
|
2023
Q3 | $497K | Buy |
5,614
+1,624
| +41% | +$144K | ﹤0.01% | 1923 |
|
|
2023
Q2 | $346K | Sell |
3,990
-1,045
| -21% | -$90.6K | ﹤0.01% | 2163 |
|
|
2023
Q1 | $490K | Buy |
5,035
+534
| +12% | +$51.9K | ﹤0.01% | 1982 |
|
|
2022
Q4 | $466K | Buy |
4,501
+448
| +11% | +$46.4K | ﹤0.01% | 2004 |
|
|
2022
Q3 | $344K | Buy |
4,053
+242
| +6% | +$20.5K | ﹤0.01% | 2007 |
|
|
2022
Q2 | $316K | Sell |
3,811
-827
| -18% | -$68.6K | ﹤0.01% | 2176 |
|
|
2022
Q1 | $358K | Sell |
4,638
-3,487
| -43% | -$269K | ﹤0.01% | 2186 |
|
|
2021
Q4 | $718K | Sell |
8,125
-2,913
| -26% | -$257K | ﹤0.01% | 1800 |
|
|
2021
Q3 | $853K | Buy |
11,038
+2,488
| +29% | +$192K | ﹤0.01% | 1686 |
|
|
2021
Q2 | $713K | Sell |
8,550
-3,001
| -26% | -$250K | ﹤0.01% | 1823 |
|
|
2021
Q1 | $873K | Sell |
11,551
-1,953
| -14% | -$148K | ﹤0.01% | 1660 |
|
|
2020
Q4 | $1.18M | Sell |
13,504
-6,828
| -34% | -$599K | ﹤0.01% | 1383 |
|
|
2020
Q3 | $1.55M | Buy |
+20,332
| New | +$1.55M | ﹤0.01% | 1170 |
|
|
2020
Q2 | – | Sell |
-111,158
| Closed | -$9.39M | – | 2400 |
|
|
2020
Q1 | $9.39M | Buy |
111,158
+93,218
| +520% | +$7.88M | 0.02% | 500 |
|
|
2019
Q4 | $1.52M | Buy |
17,940
+6,426
| +56% | +$543K | ﹤0.01% | 1248 |
|
|
2019
Q3 | $776K | Sell |
11,514
-1,024
| -8% | -$69K | 0.01% | 494 |
|
|
2019
Q2 | $1.07M | Sell |
12,538
-2,063
| -14% | -$177K | 0.02% | 442 |
|
|
2019
Q1 | $1.3M | Sell |
14,601
-569
| -4% | -$50.5K | 0.02% | 425 |
|
|
2018
Q4 | $1.29M | Sell |
15,170
-923
| -6% | -$78.5K | 0.03% | 410 |
|
|
2018
Q3 | $1.56M | Buy |
16,093
+1,100
| +7% | +$107K | 0.03% | 407 |
|
|
2018
Q2 | $1.41M | Buy |
14,993
+62
| +0.4% | +$5.84K | 0.03% | 410 |
|
|
2018
Q1 | $1.21M | Buy |
14,931
+302
| +2% | +$24.5K | 0.02% | 441 |
|
|
2017
Q4 | $1.31M | Buy |
14,629
+16
| +0.1% | +$1.43K | 0.02% | 438 |
|
|
2017
Q3 | $1.36M | Buy |
14,613
+1,835
| +14% | +$171K | 0.03% | 421 |
|
|
2017
Q2 | $1.16M | Buy |
12,778
+226
| +2% | +$20.5K | 0.02% | 446 |
|
|
2017
Q1 | $1.1M | Buy |
12,552
+1,016
| +9% | +$89.2K | 0.02% | 453 |
|
|
2016
Q4 | $955K | Sell |
11,536
-121
| -1% | -$10K | 0.02% | 479 |
|
|
2016
Q3 | $1.08M | Sell |
11,657
-642
| -5% | -$59.4K | 0.02% | 458 |
|
|
2016
Q2 | $957K | Buy |
12,299
+650
| +6% | +$50.6K | 0.02% | 482 |
|
|
2016
Q1 | $961K | Buy |
11,649
+3,352
| +40% | +$277K | 0.02% | 438 |
|
|
2015
Q4 | $870K | Buy |
8,297
+1,382
| +20% | +$145K | 0.02% | 438 |
|
|
2015
Q3 | $728K | Buy |
6,915
+1,174
| +20% | +$124K | 0.02% | 470 |
|
|
2015
Q2 | $785K | Buy |
5,741
+1,666
| +41% | +$228K | 0.02% | 432 |
|
|
2015
Q1 | $508K | Buy |
4,075
+792
| +24% | +$98.7K | 0.01% | 523 |
|
|
2014
Q4 | $297K | Sell |
3,283
-149
| -4% | -$13.5K | 0.01% | 635 |
|
|
2014
Q3 | $247K | Buy |
+3,432
| New | +$247K | 0.01% | 675 |
|